<DOC>
	<DOCNO>NCT01379261</DOCNO>
	<brief_summary>The purpose study determine whether treatment patient suffer ST-elevation myocardial infarction ( STEMI ) 1-2 liter cold saline central venous catheter cool Philips InnerCool RTx Endovascular System prior percutaneous coronary intervention ( PCI ) result reduction infarct size .</brief_summary>
	<brief_title>Efficacy Endovascular Catheter Cooling Combined With Cold Saline Treatment Acute Myocardial Infarction</brief_title>
	<detailed_description>Acute myocardial infarction ( AMI ) lead cause mortality western world today . Although reperfusion ischemic myocardium prerequisite myocardial salvage , describe reperfusion may cause additional damage myocardium ( reperfusion injury ) . In safety &amp; feasibility trial RAPID MI-ICE demonstrate treatment patient suffer STEMI 1-2 liter cold saline central venous catheter cool Philips InnerCool RTx Endovascular System prior PCI feasible , safe result 38 % reduction infarct size/myocardium risk . The aim present study confirm find large multicenter trial . The study randomize , control , evaluator blind , multicenter trial enrol 120 patient ten site .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Reperfusion Injury</mesh_term>
	<mesh_term>Myocardial Reperfusion Injury</mesh_term>
	<mesh_term>Anterior Wall Myocardial Infarction</mesh_term>
	<mesh_term>Inferior Wall Myocardial Infarction</mesh_term>
	<criteria>1 . Clinical symptom sign myocardial infarction 12lead ECG provide evidence ongoing acute myocardial infarction , involve large area myocardium , define follow ECG criterion . The ECG change present upon arrival cath lab : 1 . Anterior infarct : STsegment elevation &gt; 0.2mV measure 0.08 sec J point 2 anatomically contiguous precordial lead , V1 V4 ; and/or &gt; 0.2mV lead V5 V6 . 2 . Inferior infarct : ST elevation &gt; 0.2mV measure 0.08 sec J point 2 anatomically contiguous inferior lead , couple ST depression 2 contiguous anterior lead total ST deviation ( inferior ST elevation plus anterior ST depression ) &gt; 0.8mV . 2 . Present study PCI lab within six ( 6 ) hour onset acute cardiac ischemic sign symptom ( chest pain pressure , arm jaw pain , dyspnea , nausea/vomiting , syncope ) . 3 . Be candidate PCI PCI plan immediate intervention . 4 . Be willing able comply study procedure , include return MRI scan 4 Â±2 day available additional follow Subject understand study procedure agree participate study give write informed consent . 5 . Be Killips Class I . 1 . Age less eighteen ( &lt; 18 ) year age 2 . Age great equal eighty ( 80 ) year age 3 . Are pregnant . 4 . Having aortic dissection 5 . History prior large myocardial infarct infarct segment currently affect . 6 . Acute administration thrombolytic agent qualify MI 7 . Clinical suspicion nonthrombotic ( e.g. , pericarditis , vasospasm , takotsubo , illicit drug use ) cause STsegment elevation determine investigator 8 . If ( screen process ) determination make sitestudy personnel initiation cool prior diagnostic coronary angiography technically feasible reason ( patient randomize Hypothermia Arm ) , prospective subject enrol . 9 . Known risk heparin induce thrombocytopenia ( HIT ) 10 . Require immediate surgical procedural intervention PCI ( e.g . CABG ) 11 . Present cardiogenic shock endstage cardiomyopathy 12 . Have undergone least ten ( 10 ) minute cardiopulmonary resuscitation ( CPR ) prior presentation PCI facility 13 . History surgical coronary artery revascularization ( e.g . CABG ) 14 . Active bleeding , coagulopathy , contraindication placement heparincoated 14F central venous catheter via 14F femoral venous introducer sheath ( e.g. , known history heparin induce thrombocytopenia , IVC filter ) 15 . Contraindications hypothermia 16 . Personal familial history malignant hyperthermia 17 . Known endstage renal disease ( ESRD ; e.g. , dialysis , statuspost renal transplant ) , know severe hepatic failure ( e.g. , cirrhosis , acute hepatitis ) , contraindication receive meperidine ( use MAO inhibitor within previous 14 day , history seizure , history hypersensitivity meperidine , etc. ) . 18 . Serious concurrant medical condition likely result death next 12 month . Any acute chronic condition Investigator believe unacceptably increase risk study participation interfere study procedure assessment . 19 . Contraindication MRI ( e.g. , cardiac pacemaker , ICD , nerve stimulator , brain aneurysm clip , cochlear implant , claustrophobia ) 20 . Deemed unsuitable investigator participate study . 21 . Active recent ( within 1 month prior study enrollment ) participation another investigational clinical research study . 22 . Enrollment plan enrol another study AMI therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>STEMI</keyword>
	<keyword>primary PCI</keyword>
	<keyword>Hypothermia</keyword>
	<keyword>Endovascular cooling</keyword>
	<keyword>Cardiac MRI</keyword>
</DOC>